If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,863.00
Bid: 4,843.00
Ask: 4,847.00
Change: 32.00 (0.66%)
Spread: 4.00 (0.083%)
Open: 4,857.00
High: 4,932.00
Low: 4,837.00
Prev. Close: 4,831.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Croda acquires fragrance business Parfex

7 Apr 2021 07:00

RNS Number : 5770U
Croda International PLC
07 April 2021
 

Croda expands Iberchem's fragrances offering with the acquisition of Parfex

 

7 April 2021

 

Croda International Plc ("Croda") today announces that its fragrances and flavours subsidiary, Iberchem, has agreed to acquire Parfex S.A. ("Parfex"), a fine fragrance business based in Grasse, France, for a total enterprise value of €45 million.

 

Established in 1985 and now employing 75 people, Parfex creates fragrances principally for premium personal care and fine perfumery markets, leveraging the natural raw materials that are available in the region. The business has seen good growth over the last decade, generating €3.6m EBITDA in 2020, and now sells its fragrances in more than 50 countries worldwide.

 

Parfex is 82% owned by its founders with the remaining free float of shares listed on the Euronext Access market. Croda has agreed to acquire 93% of Parfex's outstanding shares, comprising the founding shareholders and certain minority investors. Croda ultimately expects to acquire 100% of the total outstanding share capital, subject to a potential tender offer and subsequent de-listing.

 

Steve Foots, Croda Chief Executive Officer, said:

 

"We believe that transitioning to more natural raw materials is a potential differentiator in the fragrance market. Parfex will play an important role in Iberchem's plans to increase its sustainable fragrance offerings and further enhances our position in the creation of higher-value fine fragrances."

 

The transaction is subject to customary pre closing conditions and is expected to close by the end of the second quarter of 2021.

 

For more information, please contact:

 

Investors: David Bishop, Croda +44 7823 874428

Media: Charlie Armitstead, Teneo +44 7703 330269

 

About Croda - www.croda.com

 

Established in 1925, Croda is the name behind sustainable, high performance ingredients and technologies in some of the world's most successful brands: creating, making and selling speciality chemicals that are relied on by industries and consumers everywhere.

 

Croda is a FTSE 100 company with over 5,600 passionate and innovative employees, working across manufacturing sites and offices around the world with a shared Purpose to use Smart Science to Improve Lives™. As part of this Purpose, and with around two thirds of its organic raw materials already from bio-based sources, Croda has committed to be the most sustainable supplier of innovative ingredients, becoming Climate, Land and People Positive by 2030.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEAKLKEDAFEFA
Date   Source Headline
27th Nov 20195:13 pmRNSHolding(s) in Company
25th Nov 20193:47 pmRNSHolding(s) in Company
22nd Nov 201910:17 amRNSDirector/PDMR Shareholding
12th Nov 20195:41 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
7th Nov 20196:04 pmRNSHolding(s) in Company
7th Nov 201910:04 amRNSHolding(s) in Company
1st Nov 20194:45 pmRNSDirector/PDMR Shareholding
15th Oct 20194:54 pmRNSTransaction in Own Shares
11th Oct 20195:40 pmRNSDirector/PDMR Shareholding
7th Oct 20197:00 amRNSCroda investor seminar focusing on Life Sciences
3rd Oct 20194:20 pmRNSDirector/PDMR Shareholding
13th Sep 20192:27 pmRNSDirector/PDMR Shareholding
11th Sep 20193:00 pmRNSDirector/PDMR Shareholding
11th Sep 20192:28 pmRNSHolding(s) in Company
13th Aug 20194:12 pmRNSDirector/PDMR Shareholding
25th Jul 20193:35 pmRNSDirector/PDMR Shareholding
24th Jul 20197:00 amRNSResults for the six months ended 30 June 2019
11th Jul 20193:11 pmRNSDirector/PDMR Shareholding
14th Jun 20193:01 pmRNSDirector/PDMR Shareholding
4th Jun 20193:24 pmRNSDirector/PDMR Shareholding
13th May 20193:20 pmRNSDirector/PDMR Shareholding
3rd May 20192:59 pmRNSDirector/PDMR Shareholding
1st May 20194:32 pmRNSDirector/PDMR Shareholding
29th Apr 20198:54 amRNSTotal Voting Rights
26th Apr 20198:21 amRNSTotal Voting Rights
25th Apr 201910:25 amRNSDirectorate Change
25th Apr 20199:53 amRNSResult of AGM
12th Apr 20194:28 pmRNSDirector/PDMR Shareholding
8th Apr 20194:45 pmRNSDirector/PDMR Shareholding
4th Apr 20199:32 amRNSDirector/PDMR Shareholding
2nd Apr 20199:04 amRNSDirector/PDMR Shareholding
28th Mar 201911:13 amRNSDirector/PDMR Shareholding
26th Mar 20198:16 amRNSDirector/PDMR Shareholding
18th Mar 20195:26 pmRNSAnnual Financial Report
13th Mar 20191:42 pmRNSDirector/PDMR Shareholding
12th Mar 20192:22 pmRNSDirector/PDMR Shareholding
12th Mar 20192:21 pmRNSDirector/PDMR Shareholding
11th Mar 20192:16 pmRNSDirector/PDMR Shareholding
6th Mar 20193:53 pmRNSTransaction in Own Shares
6th Mar 201910:07 amRNSDirector/PDMR Shareholding
6th Mar 201910:07 amRNSDirector/PDMR Shareholding
6th Mar 201910:06 amRNSDirector/PDMR Shareholding
6th Mar 201910:03 amRNSDirector/PDMR Shareholding
6th Mar 201910:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.